Susan Hasty, Publisher
Table of Contents . . . May 23rd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Hepatocellular Carcinoma - Amended virus kills liver cancer cells, prevents growth of new ones
Viral Clearance - Quick turnover may mitigate effectiveness of some virus-based gene therapies
Cancer Vaccine - Cells expressing interleukin-2 arrest cancer growth and boost tumor immunity
Gene Delivery - Bovine herpesvirus 4 suitable for delivering genes to vast array of cells
Technology - Polymers are promising tools for gene therapy
DNA Research - Nanogen enters license agreement for noncoding DNA analysis
Drug Discovery - Millennium Pharmaceuticals enters knowledge management collaboration
Duchenne Muscular Dystrophy - Enzyme blocks DMD in mice
Funding - Lynx arranges $22.6 million in private equity financing
Genomics - Myriad Genetics publishes major obesity gene locus
Genomics - Sequenom secures license from Genetic Technologies
Head and Neck Cancer - High dose of Advexin gene therapy provides significant survival advantage
Hemophilia - Treatment with gene delivery showing promise in bleeding disorder
Hypertrophic Cardiomyopathy - Study suggests mechanism for heart defect that kills young athletes
INGAP Peptide - Procter & Gamble announces strategic alliance treatment of diabetes mellitus
Infectious Disease - Scientists discuss microbial pathogenesis in era of bioterrorism, drug resistance
Melanoma - Transduced cells block angiogenic signals in tumor-implanted mice
Therapy - Drug discovery crisis: Can genomics companies rescue big pharma?
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.